Brief: Hemcheck Sweden Receives Order In Budapest
June 8 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* HAS RECEIVED A FIRST EVALUATION ORDER FROM THE HEIM PÁL
NATIONAL
PEDIATRIC INSTITUTE IN BUDAPEST, HUNGARY
* ORDER IS OF MINOR FINANCIAL VALUE BUT THERE IS A
POSSIBILITY OF
MORE AND LARGER ORDERS IN THE FUTURE
* ORDER IS FOR HAEMOLYSIS DETECTION FOR DIAGNOSTIC USE
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln